Target intelligence / Profile preview

Burn wound eschar proteins

Molecular classification
Extracellular matrix protein, Other
01

Overview

Burn wound eschar proteins represent the necrotic, denatured proteinaceous material that forms on the surface of skin following a deep-partial or full-thickness thermal injury. This complex substrate is primarily composed of thermally damaged extracellular matrix (ECM) components, such as denatured collagen, fibrin, and elastin, which lose their native structure and function (Singer et al., 2017, Journal of Burn Care & Research). The presence of eschar is pathological as it prevents the formation of granulation tissue and serves as a reservoir for microbial colonization (StatPearls, 2023, Burn Resuscitation and Management). Furthermore, thick eschar can cause mechanical constriction, potentially leading to compartment syndrome in circumferential burns. Pharmacologically, these proteins are the primary target for enzymatic debridement agents like NexoBrid, which is a concentrate of proteolytic enzymes enriched in bromelain (EMA, 2012, NexoBrid Assessment Report). These therapeutic agents work by selectively hydrolyzing the peptide bonds within the denatured eschar proteins, facilitating the non-surgical removal of dead tissue while preserving viable dermal structures. Effective targeting of these proteins is crucial for preparing the wound bed for subsequent healing or surgical grafting. Compared to surgical excision, enzymatic targeting of eschar proteins can reduce blood loss and the need for autografting.

Other names
Burn escharNecrotic burn tissueDevitalized tissue proteinsDenatured extracellular matrix proteins
02

Mechanism of action

Enzymatic proteolysis and degradation of denatured protein components within the necrotic tissue to facilitate debridement.

03

Biological functions

Wound healingOther
04

Disease associations

InflammationInfectionOther
05

Safety considerations

Non-selective proteolysis of healthy tissuePain at application siteRisk of bleedingSystemic absorption of enzymes
06

Interacting drugs

Bromelain

4 more in the full profile.

07

Biomarkers

Eschar thicknessWound bed vascularizationPercent of eschar removal

Beyond the preview

Go deeper on Burn wound eschar proteins.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Burn wound eschar proteins.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call